0.00Open10.95Pre Close0 Volume9 Open Interest70.00Strike Price0.00Turnover67.17%IV2.25%PremiumDec 27, 2024Expiry Date9.17Intrinsic Value100Multiplier4DDays to Expiry1.78Extrinsic Value100Contract SizeAmericanOptions Type0.9662Delta0.0134Gamma8.47Leverage Ratio-0.0524Theta0.0074Rho8.18Eff Leverage0.0063Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet